Inventor · disambiguated record
Dirk Kosemund
Also filed as: KOSEMUND DIRK
43 granted patents·32 pending applications·153 citations·filing 2000–2022
96Inventor score
Top patents by PatentIndex Score
75 records- 0192US7414043B29-α-substituted estratrienes as selectively active estrogensSCHERING AG·Filed 2003·Granted Aug 19, 2008·56 cites·26 claims
- 0288US11998539B2Substituted aminoquinolones as DGKalpha inhibitors for immune activationBAYER AG·Filed 2022·Granted Jun 4, 2024·1 cites·24 claims
- 0386US7511059B2Thiazolidinones, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2006·Granted Mar 31, 2009·14 cites·15 claims
- 0483US8916557B2Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-aminesLücking Ulrich·Filed 2012·Granted Dec 23, 2014·4 cites·15 claims
- 0582US9388140B2Substituted benzimidazolesKLAR ULRICH·Filed 2012·Granted Jul 12, 2016·3 cites·18 claims
- 0680US9670202B2Substituted triazolopyridinesBayer Pharma AG·Filed 2014·Granted Jun 6, 2017·2 cites·16 claims
- 0779US9133171B2Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Sep 15, 2015·5 cites·13 claims
- 0879US6583130B1C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compoundsSCHERING AG·Filed 2000·Granted Jun 24, 2003·18 cites·8 claims
- 0978US7504410B2Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agentsSCHERING AG·Filed 2003·Granted Mar 17, 2009·13 cites·22 claims
- 1076US7449459B2Inhibitors of soluble adenylate cyclaseBAYER SCHERING PHARMA AG·Filed 2007·Granted Nov 11, 2008·4 cites·22 claims
- 1175US9669034B24-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Jun 6, 2017·2 cites·12 claims
- 1275US9255100B2Substituted imidazopyridazinesKLAR ULRICH·Filed 2011·Granted Feb 9, 2016·3 cites·14 claims
- 1374US7427610B22-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour actionSTERIX LTD·Filed 2004·Granted Sep 23, 2008·8 cites·21 claims
- 1473US9877954B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2017·Granted Jan 30, 2018·1 cites·15 claims
- 1572US9540392B2ThienopyrimidinesBayer Pharma AG·Filed 2013·Granted Jan 10, 2017·2 cites·10 claims
- 1670US9650340B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted May 16, 2017·1 cites·9 claims
- 1769US9499492B24-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted Nov 22, 2016·1 cites·14 claims
- 1869US7109360B116-hydroxyestratrienes as selectively active estrogensSCHERING AG·Filed 2000·Granted Sep 19, 2006·6 cites·13 claims
- 1967US9108926B2Disubstituted 5-fluoro-pyrimidinesLücking Ulrich·Filed 2012·Granted Aug 18, 2015·1 cites·11 claims
- 2066US9199999B2Substituted imidazopyrazinesKLAR ULRICH·Filed 2011·Granted Dec 1, 2015·1 cites·5 claims
- 2165US9663510B2Substituted triazolopyridines and their use as TTK inhibitorsBAYER IP GMBH·Filed 2012·Granted May 30, 2017·1 cites·27 claims
- 2265US9284317B2Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitorsKOPPITZ MARCUS·Filed 2011·Granted Mar 15, 2016·1 cites·10 claims
- 2365US9212184B26-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitorsKOPPITZ MARCUS·Filed 2011·Granted Dec 15, 2015·1 cites·10 claims
- 2463US8551980B2Substituted triazolopyridinesSCHULZE VOLKER·Filed 2010·Granted Oct 8, 2013·1 cites·13 claims
- 2562US2023167078A1Substituted aminothiazoles as dgkzeta inhibitors for immune activationBAYER AG·Filed 2021·Application pending·0 cites
- 2661US6794409B2Use of ERβ-selective ligands for regulating fertility and compounds useful thereforSCHERING AG·Filed 2002·Granted Sep 21, 2004·1 cites·27 claims
- 2759US6670347B219-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ringSCHERING AG·Filed 2001·Granted Dec 30, 2003·2 cites·32 claims
- 2857US12478621B2Substituted aminoquinolones as dgkalpha inhibitors for immune activationBAYER AG·Filed 2020·Granted Nov 25, 2025·0 cites·17 claims
- 2957US9770445B2Sulfoximine substituted 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives and their use as CDK9 kinase inhibitorsBayer Pharma AG·Filed 2014·Granted Sep 26, 2017·0 cites·12 claims
- 3056US2008132476A1Substituted estratrienes as selectively active estrogensKOSEMUND DIRK·Filed 2008·Application pending·0 cites
- 3155US8492570B22-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor actionHILLISCH ALEXANDER·Filed 2008·Granted Jul 23, 2013·0 cites·5 claims
- 3254US2010048891A1Metasubstituted thiazolidinones, their manufacture and use as a drugSCHULZE KLAUSE·Filed 2009·Application pending·0 cites
- 3354US2024174683A1Map4k1 inhibitorsBAYER AG·Filed 2022·Application pending·0 cites
- 3453US2006270845A116-Hydroxyestratrienes as selectively active estrogensKUENZER HERMANN·Filed 2006·Application pending·0 cites
- 3552US2016159816A1Substituted thienopyrimidines and pharmaceutical use thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3650US2003130249A1Therapeutic use of estrogen receptor (ER)beta-selective agonists for triggering somatotropic, organotropic and anticatabolic effects (somatotropic therapy)SCHERING AG·Filed 2002·Application pending·0 cites
- 3750US2005020695A1Use of ERbeta-selective ligands for regulating fertility and compounds useful thereforFiled 2004·Application pending·0 cites
- 3848US9962389B24-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine groupBAYER IP GMBH·Filed 2017·Granted May 8, 2018·0 cites·15 claims
- 3948US2023062100A1Substituted aminoquinolones as dgkalpha inhibitors for immune activationBAYER AG·Filed 2020·Application pending·0 cites
- 4048US2008255117A1SulfonyltryptophanolsWORTMANN LARS·Filed 2008·Application pending·0 cites
- 4147US8841311B2Sulphone-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicamentsBUCHMANN BERND·Filed 2009·Granted Sep 23, 2014·0 cites·7 claims
- 4247US2008287493A1Arylmethylen substituted n-acyl-y-aminoalcoholsWORTMANN LARS·Filed 2008·Application pending·0 cites
- 4346US2007015759A1Metasubstituted thiazolidinones, their manufacture and use as a drugSCHULZE VOLKER K·Filed 2005·Application pending·0 cites
- 4446US2009082372A1Arylmethylene Substituted N-Acyl-Beta-Amino AlcoholsWORTMANN LARS·Filed 2008·Application pending·0 cites
- 4546US2015259300A14-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfone groupBayer Pharma AG·Filed 2013·Application pending·0 cites
- 4645US9670161B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone groupBayer Pharma AG·Filed 2013·Granted Jun 6, 2017·0 cites·5 claims
- 4745US2008207728A1Bicyclic acyltryptophanolsWORTMANN LARS·Filed 2007·Application pending·0 cites
- 4844US9708293B2N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone groupBayer Pharma AG·Filed 2013·Granted Jul 18, 2017·0 cites·12 claims
- 4944US9586958B2Prodrug derivatives of substituted triazolopyridinesBayer Pharma AG·Filed 2014·Granted Mar 7, 2017·0 cites·14 claims
- 5044US2008221195A11,2-diarylacetylene derivatives of acyltryptophanolsWORTMANN LARS·Filed 2007·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dirk Kosemund files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →